USPSTF: Decision to Undergo PSA Screening Should Be Individual
C recommendation for men aged 55 to 69 years; USPSTF recommends against screening for age 70+
Intravesical Gemcitabine Therapy Cuts Bladder Cancer Recurrence
Immediate post-resection gemcitabine reduces recurrence over 4 years in low-grade bladder cancer
Cancer Incidences and Burden Expected to Shift in HIV-Positive
Prostate and lung cancer expected to emerge as the most common types by 2030
FDA Approves Drug Combo for Aggressive Thyroid Cancer
Dabrafenib + trametinib approved to treat BRAF-positive anaplastic thyroid cancer
Poor Prognosis for Interval Breast Cancer After Negative Mammo
Odds of poor prognosis after mammography with negative results higher for younger women
Parenting Fears Harm Well-Being of Women With Metastatic Cancer
Findings based on survey of women with advanced cancer and dependent children
Screening Mammos Linked to Less Aggressive Tx If Diagnosed
Women aged 40 to 49 years with no mammogram have increased odds of positive nodes, larger tumors
Early Intervention May Reduce Breast CA-Related Lymphedema
Bioimpedance spectroscopy monitoring with early interventions lowers need for aggressive treatment
Many Organizations Not Meeting Trial Reporting Requirements
Only 19 percent of organizations use computer software to monitor compliance with Final Rule
Gender Disparity Observed in Cancer Genetic Testing in the U.S.
Unaffected men have rate of breast/ovarian cancer testing that is one-tenth that of unaffected women
